Is America on Too Many Psychiatric Drugs?

What It Covers

Wall Street Journal investigation reveals psychiatric drugs like benzodiazepines and antidepressants, prescribed to millions of Americans, cause severe withdrawal symptoms and side effects from long-term use that was never clinically studied or disclosed.

Key Questions Answered

• •Prescription duration mismatch: Benzodiazepines are clinically approved for two to four weeks maximum use, yet patients stay on them from two weeks to over twenty years, with doctors often increasing doses when side effects emerge instead of recognizing drug-induced problems.
• •Withdrawal severity underreported: Studies show fifteen to forty-four percent of chronic benzo users experience moderate to severe withdrawal symptoms, while nearly two-thirds of patients on antidepressants for over two years face withdrawal issues including brain zaps, panic attacks, and chemical anxiety that can last months.
• •Clinical trial gap: Most antidepressant studies last only eight weeks, but the average American takes them for five years. With 347 million antidepressant prescriptions written annually in the US, patients essentially serve as an unstudied long-term experiment with unknown neurological consequences.
• •Informed consent failure: Doctors routinely prescribe psychiatric medications without warning patients about potential long-term neurological damage, dependency risks, or withdrawal severity. Patients discover these effects only after experiencing them, often spending over $100,000 on specialized treatment to safely discontinue the drugs.